Printable: What are the options for a myeloma patient who has relapsed on a two-drug combination?

What are the options for a myeloma patient who has relapsed on a two-drug combination? (https://www.myeloma.org/videos/are-options-myeloma-patient-who-has-relapsed-two-drug-combination)

In this week’s video, Dr. Brian G.M. Durie advises that patients discuss with their doctors the many aspects of various treatments, including possible toxicities, cost issues, the patient’s overall health, and the patient’s age.

BOTTOM LINE:
Discuss with your doctor if you should choose a two-drug combination versus a three-drug combination.

Author

Dr. Brian GM Durie (https://www.myeloma.org/Brian-Durie-md)

Video

Series

Ask Dr. Durie (https://www.myeloma.org/taxonomy/term/19)

Old Id

787

Ask a Question

Please note that Ask Dr. Durie has been discontinued, and it was designed to address myeloma questions of the broadest possible audience interest. If you have a question of a personal nature, please contact our InfoLine Coordinators at 800.452.2873 or [email protected] (mailto:[email protected]) (Please do not send email attachments or lab reports.).

Image of Dr. Brian G.M. Durie Dr. Brian G.M. Durie (1942-2025) was the co-founder of the IMF. He was a Professor of Medicine, Hematologist/Oncologist, and Honoree MD at the University of Brussels.